Search
Remarks by Dr. Sharpless at the FDA Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds - 05/31/2019
… Thank you for joining FDA today for this public hearing titled “Scientific Data and Information About … attendees, and those unable to participate in today’s hearing – to submit comments to our docket on this topic, … group to address these data gaps specifically. You’ll be hearing more from this group in the months to come. FDA is …
FDA In Brief: FDA approval of soy leghemoglobin as a color additive is now effective
… containing objections to the final rule and request for a hearing. Under the law, the effective date of the final rule … not provide any substantive evidence that would justify a hearing or otherwise provide a basis for revoking the … to the regulations. Therefore, the agency is denying the hearing request. The stay of the effective date of the final …
FDA Roundup: May 09, 2023
… a new web page with details about over-the-counter (OTC) Hearing Aids: What You Should Know before and after buying an OTC hearing aid. COVID-19 testing updates: As of today, 449 …
FDA is Committed to Sound, Science-based Policy on CBD
… of the issue was center stage at the FDA’s recent public hearing , on May 31st, where the Agency provided stakeholders … of CBD, there were several significant takeaways from the hearing. Several commenters expressed a desire for a … expressed and information shared during the recent public hearing, including new scientific data, and we look forward …
Remarks by Lauren Silvis, Chief of Staff, to the Consumer Health Products Association Regulatory, Scientific, and Quality Conference - 05/21/2019
… the DFL and labeling are not sufficient. We’re open to hearing from sponsors who want to pursue this approach in the … the regulatory path forward, FDA is holding a public hearing on May 31 to obtain additional scientific data and … related to cannabis and cannabis-derived compounds. This hearing is expected to be an important step in our continued …
Final All Hands Meeting with Dr. Gottlieb - 04/04/2019
… times in the past two years. The only major Congressional hearing where I didn’t testify was the one hearing on OTC drug reform where Janet Woodcock told me I …
Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products
… of stakeholders interested in CBD. We held a public hearing in May 2019 and issued a call to stakeholders to work … data on CBD. The FDA re-opened the May 2019 public hearing docket , and will keep it open in the future as one …
Advancing Nutrition, Healthy Food Options and Front-of-Package Labeling
… significance of front-of-package labeling, we are hearing substantial interest from a wide variety of …
Highlighting Major Issues Critical to FDA Across Our Diverse Agency After One Year Back
… available, and they have done that well. In the oversight hearing of February 8th, I was able to defend our staff’s …
Remarks by Commissioner Califf to the 2022 FDLI Annual Conference - 06/14/2022
Remarks by FDA Commissioner Robert M. Califf to the Coalition for Health AI (CHAI) - 03/05/2024
… data as a “one-off” activity. Not surprisingly, I’m hearing that the “effectiveness” metric being used by health …
Remarks by Anna Abram to the Biocom Celebration of Life Dinner - 11/21/2019
… and interchangeable insulin products. We held a public hearing to seek public input on the topic and we have been …
Remarks by Dr. Susan Mayne, Director of the Center for Food Safety and Applied Nutrition at the Food and Drug Law Institutes 2023 Annual Conference - 05/17/2023
… for this during my tenure which included testifying in a hearing on the Hill about this topic. Second, the FDA is …